Medical Editor: John P. Cunha, DO, FACOEP
Buminate [albumin (Human)] 25% injection is albumin, the protein portion of the blood, used to treat shock, burns, or low blood protein. Buminate is available in generic form. Side effects of Buminate are rare but may include:
Buminate 25% is administered by IV injection. The dosage depends on the condition being treated. Buminate 25% may interact with other drugs. Tell your doctor all medications and supplements you take. During pregnancy, Buminate 25% should be given only if clearly needed. It is not known whether Buminate 25% passes into breast milk. Consult your doctor before breastfeeding.
Our Buminate 25% Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Adverse Reactions From Clinical Trials
There are no data available on adverse reactions from Baxalta-sponsored clinical trials conducted with BUMINATE 25%.
Post-Marketing Adverse Reactions
The following adverse reactions have been reported in the post-marketing experience.
Immune System Disorders : Anaphylactic shock, anaphylactic reaction, hypersensitivity/allergic reactions
Nervous System Disorders : Headache, dysgeusia
Vascular Disorders : Hypotension, flushing
Gastrointestinal Disorders : Vomiting, nausea
General Disorders and Administration Site Conditions : Pyrexia, chills
Read the entire FDA prescribing information for Buminate (Albumin Human, USP, 25% Solution)
© Buminate Patient Information is supplied by Cerner Multum, Inc. and Buminate Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.